Clinical Trial

AI-Assisted Optimization of Online Adaptive Radiotherapy for Gastric Lymphoma

Study acronym: GLORIA
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to evaluate CBCT image-based triggered online adaptive radiotherapy (ART) and assess its clinical benefits in protecting organs at risk (OARs).
Trial Details
NCT Number NCT07609355
Lead Sponsor Sun Yat-sen University
Conditions Lymphoma of the Mucosa Associated Lymphoid Tissue (MALT)
Enrollment 25 participants
Start Date 2026-05-08
Primary Completion 2027-12-31 (estimated)
Study Completion 2029-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-27